Repetitive transcranial magnetic stimulation (rTMS) is an FDA-approved, noninvasive modality for treating major depressive disorder and obsessive-compulsive disorder. Earlier studies evaluating therapeutic effects of rTMS on symptom scores of patients with generalized anxiety disorder (GAD) and panic disorder (PD) have yielded inconsistent findings.
Methods
We performed a systematic review and meta-analysis of inter-ventional studies assessing the effect of rTMS on symptom scores in patients with GAD or PD with or without psychiatric comorbidities using studies published up to April 2021. We used DerSimonian-Laird random effects models to obtain pooled standardized mean difference (SMD) and 95% CI.
Results
A total of 13 studies consisting of 677 participants (404 treated with rTMS and 273 without rTMS) were included in this meta-analysis. In GAD patients with or without any comorbidities, rTMS therapy demonstrated significant improvements in anxiety (SMD = 1.45; P < .001) and depression (SMD = 1.65; P < .001) scores regardless of rTMS parameters. Overall anxiety (SMD = 0.24; P = .48) and panic severity (SMD = 1.19; P = .054) scores did not significantly improve after rTMS therapy in patients with PD.
Conclusions
rTMS is safe and improves anxiety and depression scores only in GAD patients, regardless of underlying comorbidities or rTMS parameters.
Get full access to this article
View all access options for this article.
References
1.
BaxterAJScottKMVosT. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013; 43: 897–910. doi:10.1017/S003329171200147X
2.
KesslerRCPetukhovaMSampsonNA. Twelvemonth and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012; 21: 169–184. doi:10.1002/mpr.1359
3.
BandelowBMichaelisS.Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015; 17: 327–335. doi:10.31887/DCNS.2015.17.3/bbandelow
4.
DuvalERJavanbakhtALiberzonI.Neural circuits in anxiety and stress disorders: a focused review. Ther Clin Risk Manag. 2015; 11: 115–126. doi:10.2147/TCRM.S48528
5.
MartinEIResslerKJBinderE. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin Lab Med. 2010; 30: 865–891. doi: 10.1016/j.cll.2010.07.006
6.
PatriquinMAMathewSJ. The neurobiologi-cal mechanisms of generalized anxiety disorder and chronic stress. Chronic Stress (Thousand Oaks). 2017; 1: 2470547017703993. doi:10.1177/2470547017703993
7.
ComerJSBlancoCHasinDS. Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC). J Clin Psychiatry. 2011; 72: 43–50. doi:10.4088/JCP.09m05094blu
CuijpersPSijbrandijMKooleS. Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin Psychol Rev. 2014; 34: 130–140. doi:10.1016/j.cpr.2014.01.002
11.
HunotVChurchillRSilva de LimaM, . Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev. 2007; 2007: CD001848. doi: 10.1002/14651858. CD001848.pub4
12.
Sanchez-MecaJRosa-AlcazarAIMarin-MartinezF. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin Psychol Rev. 2010; 30: 37–50. doi:10.1016/j.cpr.2009.08.011
13.
CowleyDSHaEHRoy-ByrneP P. Determinants of pharmacologic treatment failure in panic disorder. J Clin Psychiatry. 1997; 58: 555–561. doi:10.4088/jcp.v58n1208
CirilloPGoldAKNardiAE. Transcranial magnetic stimulation in anxiety and trauma-related disorders: a systematic review and meta-analysis. Brain Behav. 2019; 9: e01284. doi:10.1002/brb3.1284
16.
KanRLDZhangBBBZhangJJQ. Non-invasive brain stimulation for posttraumatic stress disorder: a systematic review and meta-analysis. Transl Psychiatry. 2020; 10: 168. doi:10.1038/s41398-020-0851-5
17.
YanTXieQZhengZ. Different frequency repetitive transcranial magnetic stimulation (rTMS) for posttraumatic stress disorder (PTSD): a systematic review and meta-analysis. J Psychiatr Res. 2017; 89: 125–135. doi:10.1016/j.jpsychires.2017.02.021
18.
HarrisAReeceJ.Transcranial magnetic stimulation as a treatment for posttraumatic stress disorder: a meta-analysis. J Affect Disord. 2021; 289: 55–65. doi:10.1016/j.jad.2021.04.003
19.
Van AmeringenM, SimpsonW, PattersonB, . Panic attacks in generalized anxiety disorder. J Nerv Ment Dis. 2013; 201: 52–55. doi:10.1097/NMD.0b013e31827ab1f6
20.
ChavanneAVRobinsonOJ. The overlapping neurobiology of induced and pathological anxiety: a meta-analysis of functional neural activation. Am J Psychiatry. 2021; 178: 156–164. doi:10.1176/appi.ajp.2020.19111153
21.
ChantarujikapongSIScherrerJ FXianH. A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Psychiatry Res. 2001; 103: 133–145. doi:10.1016/s0165-1781(01)00285-2
22.
CuiHJiangLWeiY. Efficacy and safety of repetitive transcranial magnetic stimulation for generalised anxiety disorder: a meta-analysis. Gen Psychiatr. 2019; 32: e100051. doi:10.1136/gpsych-2019-100051
23.
DwivediAKShuklaR.Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features. Cancer Rep (Hoboken). 2020; 3: e1211. doi:10.1002/cnr2.1211
SlimKNiniEForestierD. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003; 73: 712–716. doi:10.1046/j.1445-2197.2003.02748.x
26.
NahlehZBotrusGDwivediA. Bevacizumab in the neoadjuvant treatment of human epidermal growth factor receptor 2-negative breast cancer: a meta-analysis of randomized controlled trials. Mol Clin Oncol. 2019;10(3)357–365.
27.
MantovaniALisanbySHPieracciniF. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. J Affect Disord. 2007; 102: 277–280. doi:10.1016/j.jad.2006.11.027
28.
WhiteDTavakoliS.Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder. Ann Clin Psychiatry. 2015; 27: 192–196.
29.
PraskoJZáleskýRBaresM. The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett. 2007; 28: 33–38.
30.
BystritskyAKaplanJ TFeusnerJD. A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder. J Clin Psychiatry. 2008; 69: 1092–1098. doi:10.4088/jcp.v69n0708
31.
MantovaniAAlyMDaganY. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. J Affect Disord. 2013; 144: 153–159. doi:10.1016/j.jad.2012.05.038
32.
DeppermannSVennewaldNDiemerJ. Does rTMS alter neurocognitive functioning in patients with panic disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMS. Biomed Res Int. 2014; 2014: 542526. doi:10.1155/2014/542526
33.
DiefenbachGJBragdonLBZertucheL. Repetitive transcranial magnetic stimulation for generalised anxiety disorder: a pilot randomised, double-blind, sham-controlled trial. Br J Psychiatry. 2016; 209: 222–228. doi:10.1192/bjp.bp.115.168203
34.
DilkovDHawkenERKaludievE. Repetitive transcranial magnetic stimulation of the right dorsal lateral prefrontal cortex in the treatment of generalized anxiety disorder: a randomized, double-blind sham controlled clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 78: 61–65. doi:10.1016/j.pnpbp.2017.05.018
35.
HuangZLiYBianchiMT. Repetitive transcranial magnetic stimulation of the right parietal cortex for comorbid generalized anxiety disorder and insomnia: a randomized, double-blind, sham-controlled pilot study. Brain Stimul. 2018; 11: 1103–1109. doi:10.1016/j.brs.2018.05.016
36.
KumarSSinghSParmarA. Effect of high-frequency repetitive transcranial magnetic stimulation (rTMS) in patients with comorbid panic disorder and major depression. Australas Psychiatry. 2018; 26: 398–400. doi:10.1177/1039856218771517
37.
LuRZhangCLiuY. The effect of bilateral low-frequency rTMS over dorsolateral prefrontal cortex on serum brain-derived neurotropic factor and serotonin in patients with generalized anxiety disorder. Neurosci Lett. 2018; 684: 67–71. doi:10.1016/j.neulet.2018.07.008
38.
ClarkeEClarkePGillS. Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders. J Affect Disord. 2019; 252: 435–439. doi:10.1016/j.jad.2019.03.085
39.
ZhangTZhuJXuL. Add-on rTMS for the acute treatment of depressive symptoms is probably more effective in adolescents than in adults: evidence from real-world clinical practice. Brain Stimul. 2019; 12: 103–109. doi:10.1016/j.brs.2018.09.007
40.
CarpenterJKAndrewsLAWitcraftSM. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018; 35: 502–514. doi:10.1002/da.22728
41.
MitteK.A meta-analysis of the efficacy of psycho-and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord. 2005; 88: 27–45. doi: 10.1016/j.jad.2005.05.003
42.
FeeserMPrehnKKazzerP. Transcranial direct current stimulation enhances cognitive control during emotion regulation. Brain Stimul. 2014; 7: 105–112. doi:10.1016/j.brs.2013.08.006
43.
KelleyNJHortensiusRHarmon-JonesE.When anger leads to rumination: induction of relative right frontal cortical activity with transcranial direct current stimulation increases anger-related rumination. Psychol Sci. 2013; 24: 475–481. doi:10.1177/0956797612457384
44.
ConnollyKRHelmerACristanchoMA. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry. 2012; 73: e567–e573. doi:10.4088/JCP.11m07413
